Evidence map›Paper›PMID 42797758›Full record

ArticleViruses2026

Preliminary Immunological Evaluation of Alginate Microparticles Loaded with Recombinant VP2 as an Immersion-Delivered Antigen Against Infectious Pancreatic Necrosis Virus (IPNV) in Salmonids.

Yosvania Hevia, Tomás Cancino, Yesseny Vásquez-Martínez, Francisca Tapia, Carla Arancibia, Natalia Riquelme, Iván Valdés, Marcelo Cortez-San Martín

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosvania HeviaFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Tomás CancinoLaboratorios Veterquimica SA, Santiago 9200000, Chile.
Yesseny Vásquez-MartínezFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.ORCID 0000-0002-4184-9815
Francisca TapiaFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Carla ArancibiaDepartamento de Ciencia y Tecnología de Alimentos, Universidad de Santiago de Chile, Santiago 9170022, Chile.ORCID 0000-0002-2174-3474
Natalia RiquelmeDepartamento de Ciencia y Tecnología de Alimentos, Universidad de Santiago de Chile, Santiago 9170022, Chile.ORCID 0000-0003-3490-1045
Iván ValdésLaboratorios Veterquimica SA, Santiago 9200000, Chile.
Marcelo Cortez-San MartínFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.

Funding

university of santiago de chile TDI-2401
6 · The paper itself

Abstract

Infectious pancreatic necrosis (IPN) is a highly contagious viral disease that causes significant economic losses in the global salmon farming industry. Despite the widespread use of vaccines, outbreaks caused by infectious pancreatic necrosis virus (IPNV) continue to occur, even in genetically resistant fish populations. Therefore, the development of alternative vaccination strategies remains a priority for sustainable aquaculture. In this study, we developed a vaccine prototype based on the recombinant IPNV capsid protein VP2 loaded in alginate microparticles for immersion immunization. The VP2 protein was produced using the

Indexed as

AlginatesBirnaviridae InfectionsFish DiseasesInfectious pancreatic necrosis virusSalmonidaeViral Structural ProteinsViral VaccinesAnimalsAntibodies, ViralAntigens, ViralGlucuronic AcidHexuronic AcidsProtein Subunit VaccinesRecombinant ProteinsVaccinationVaccines, SyntheticAlginatesAntibodies, ViralAntigens, ViralGlucuronic AcidHexuronic AcidsProtein Subunit VaccinesRecombinant ProteinsVaccines, SyntheticViral Structural ProteinsViral VaccinesVP2 protein, infectious pancreatic necrosis virusalginate microparticlesimmersion vaccineIPNVrecombinant proteinsalmonidsVP2

Identifiers

PMID42797758
PMCPMC13611873

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.